METHOD FOR TREATMENT OF INSULIN-DEPENDENT (TYPE I) DIABETES AND INSULIN-INDEPENDENT (TYPE II) DIABETES WITH THE CELLULAR TRANSPLANTS OF DIFFERENT ORIGIN

摘要

A method for treatment of insulin-dependent (type I) diabetes and insulin-independent (type II) diabetes with the cellular transplants of different origin comprises preparation and introduction of biological material with immunocorrective action. The individual selection of cellular preparations, correcting of metabolic, endocrine and autoimmune disorders is carried out depending on the diabetes type, presence of its complications and type of immunophysiological abnormalities. The indicated cellular preparations are introduced after the introduction of antihistaminic preparation - Tavegil, at the insulin-dependent (type I) diabetes the cryopreserved preparations of hemopoietic stem cells, made of the embryo liver of 11 weeks of gestation, is used. At the insulin-independent (type II) diabetes the cryopreserved preparations, made of cord blood, is used. The effect of treatment is evaluated by the diminishing of insulin doses which is introduced, by the origin of the hypoglycemia conditions, level of glycemia reduction, positive change of immune status indexes and biochemical indexes.